期刊文献+

手术方式对102例子宫内膜癌患者预后的影响 被引量:1

Impact of Surgical Modality on Prognosis in 102 Cases with Endometrial Cancer
下载PDF
导出
摘要 [目的]探讨子宫切除范围及淋巴结清扫术对子宫内膜癌预后的影响。[方法]对102例子宫内膜癌患者,将其中行筋膜外子宫切除手术(筋膜外组)40例与次广泛/广泛子宫切除术(广泛组)62例患者进行对照分析;行盆腔淋巴结清扫术(清扫组)48例和未行淋巴结清扫术(未清扫组)54例进行对照分析,比较其生存率。[结果]102例患者5年总的生存率为93.1%。筋膜外组与广泛组患者5年生存率比较,差异无显著性(P>0.05),但其中Ⅱ期及Ⅱ期以上患者筋膜外组、广泛组的5年生存率分别为66.7%和91.3%,有显著性差异(P=0.044)。单因素分析结果提示盆腔淋巴有转移的患者预后不良。盆腔淋巴结清扫术和未行清扫术两组生存率比较,差异无显著性(P>0.05)。[结论]盆腔淋巴转移的患者预后差,但盆腔淋巴清扫术并不改善患者预后。Ⅱ期及Ⅱ期以上患者行次广泛/广泛子宫切除术有助于改善预后。 [Purpose] To investigate the impact of the surgical dissection extension and lymphadenectomy on prognosis in patients with endometrial cancer. [Methods] Among 120 cases with endometrial cancer, survival rates were compared between intra-fascia hysterectomy (40 cases) and with sub-radical or radical hysterectomy (radical group, 62 cases), and between pelvic lymphadenectomy (48 cases) and no-lymphadenectomy (54 cases), [Results] The overall 5-year survival rate in the whole group was 93.1%. There was no significant difference in 5-year survival rate between intra-fascia group and radical group(P〉0.05), However, in patients with stage Ⅱ and over, 5- year survival between intraascia group (66.7%) and radical group (91.3%) (P=0.0440) was significant difference. Univariate analysis revealed that patients with pelvic lymph node metastasis had poor outcome, But no significant difference was found in survival between lymphodeneetomy group and no-lymphodenectomy group (P〉0.05). [Conclusionl The endometrial cancer patients with pelvic lymph node metastasis has poor outcome, but pelvic lymphadenectomy can not improve prognosis. Sub-radical/radical hysterectomy may improve progress in patients with stage Ⅱ and over.
出处 《肿瘤学杂志》 CAS 2008年第2期138-140,共3页 Journal of Chinese Oncology
关键词 子宫内膜肿瘤 子宫切除术 淋巴结切除术 预后 endometrial neoplasms hysterectomy lymphadenectomy prognosis
  • 相关文献

参考文献8

二级参考文献16

  • 1[1]Burke TV,Fowler WC,Worrow WC.Clincal aspects or risk in women with endometrial carcinoma[J].J Cell Biochem,1995,23(suppl):131-136. 被引量:1
  • 2[2]Greven KM,Lanciano RM,Corn B,et al.Pathologic stage Ⅲ endometrial carcinoma[J].Cancer,1993,71(11):3697-3702. 被引量:1
  • 3[3]Morrow CP,Bundy BN,Kurman RJ,et al.Relationship between surgical-pathological rish factors and outcome in clinical stage Ⅰand Ⅱ carcinoma of the endometrium:a Gunecologic Oncology Group study[J].Gynecol Oncol,1991,40(1):55-65. 被引量:1
  • 4[4]Genes P.Stage Ⅲ carcinoma of the endomentrium:a review of 41 cases[J].Gynecol Oncol.1987,26(1):77-86. 被引量:1
  • 5[5]Morris PC,Anderson JR,Anderson B,et al.Steriod hormone receptor content and lymph node status in endometrial cancer[J].Gynecol Oncol,1995,56(3):406-411. 被引量:1
  • 6[6]Lurain JR,Rice BL,Rademarker AW,et al.Prognostic factors associated with recurrence in clinical stage Ⅰ adenocarcinoma of the endometrium[J].Obstet Gynecol,1991,78(1):63-69. 被引量:1
  • 7[7]Mariani A,Webb MJ,Galii L,et al.Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer[J].Gynecol Oncol,2000,76(3):348-356. 被引量:1
  • 8曹泽毅,中华妇产科学,1999年,1844页 被引量:1
  • 9Chuang L,Gynecol Oncol,1995年,58期,189页 被引量:1
  • 10Ayhan A,Tuncer ZS,Tuncer R,et al.Risk factors for recurrence in clinically early endometrial carcinoma: an analysis of 183 consecutive cases[].European Journal of Obstetrics Gynecology and Reproductive Biology.1994 被引量:1

共引文献81

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部